Anti-TTI2 monoclonal antibody

Pre-made anti-TTI2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TTI2/TTI2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2206-Ab-1/ GM-Tg-hg-IP2206-Ab-2Anti-Human TTI2 monoclonal antibodyHuman
GM-Tg-rg-IP2206-Ab-1/ GM-Tg-rg-IP2206-Ab-2Anti-Rat TTI2 monoclonal antibodyRat
GM-Tg-mg-IP2206-Ab-1/ GM-Tg-mg-IP2206-Ab-2Anti-Mouse TTI2 monoclonal antibodyMouse
GM-Tg-cynog-IP2206-Ab-1/ GM-Tg-cynog-IP2206-Ab-2Anti-Cynomolgus/ Rhesus macaque TTI2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2206-Ab-1/ GM-Tg-felg-IP2206-Ab-2Anti-Feline TTI2 monoclonal antibodyFeline
GM-Tg-cang-IP2206-Ab-1/ GM-Tg-cang-IP2206-Ab-2Anti-Canine TTI2 monoclonal antibodyCanine
GM-Tg-bovg-IP2206-Ab-1/ GM-Tg-bovg-IP2206-Ab-2Anti-Bovine TTI2 monoclonal antibodyBovine
GM-Tg-equg-IP2206-Ab-1/ GM-Tg-equg-IP2206-Ab-2Anti-Equine TTI2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2206-Ab-1/ GM-Tg-hg-IP2206-Ab-2; GM-Tg-rg-IP2206-Ab-1/ GM-Tg-rg-IP2206-Ab-2;
GM-Tg-mg-IP2206-Ab-1/ GM-Tg-mg-IP2206-Ab-2; GM-Tg-cynog-IP2206-Ab-1/ GM-Tg-cynog-IP2206-Ab-2;
GM-Tg-felg-IP2206-Ab-1/ GM-Tg-felg-IP2206-Ab-2; GM-Tg-cang-IP2206-Ab-1/ GM-Tg-cang-IP2206-Ab-2;
GM-Tg-bovg-IP2206-Ab-1/ GM-Tg-bovg-IP2206-Ab-2; GM-Tg-equg-IP2206-Ab-1/ GM-Tg-equg-IP2206-Ab-2
Products NameAnti-TTI2 monoclonal antibody
Formatmab
Target NameTTI2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TTI2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2206-Ag-1Recombinant multi-species TTI2/ C8orf41/ MRT39 protein
    ORF Viral VectorpGMLP002529human TTI2 Lentivirus plasmid
    ORF Viral VectorvGMLP002529human TTI2 Lentivirus particle
    ORF Viral VectorpGMLPm003182mouse Tti2 Lentivirus plasmid
    ORF Viral VectorvGMLPm003182mouse Tti2 Lentivirus particle


    Target information

    Target IDGM-IP2206
    Target NameTTI2
    Gene ID80185,234138,290811,696776,608405,101097888,535350,100061066
    Gene Symbol and SynonymsC27H8orf41,C8orf41,MRT39,RGD1310414,TTI2
    Uniprot AccessionQ6NXR4,Q66H56
    Uniprot Entry NameTTI2_HUMAN,TTI2_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000129696
    Target ClassificationN/A

    The target: TTI2, gene name: TTI2, also named as C8orf41, MRT39. This gene encodes a regulator of the DNA damage response. The protein is a component of the Triple T complex (TTT) which also includes telomere length regulation protein and TELO2 interacting protein 1. The TTT complex is involved in cellular resistance to DNA damage stresses and may act as a regulator of phosphoinositide-3-kinase-related protein kinase (PIKK) abundance. [provided by RefSeq, May 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.